Egyptian International Pharmaceutical Industries Co. “EIPICO” (PHAR) began the construction of its 10,000 sqm biosimilars plant with an investment cost of EGP1bn. The plant construction will be under the supervision of a committee formed by the Ministry of Health which is looking to localize biosimilar and oncology drug manufacturing.
200115-PHAR-Began-Construction-of-Its-EGP1bn-Biosimilars-Plant
